CURTIS PHILLIPPI: Open Payments
NPI 1235725102 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,840 in 140 payments from 17 companies in 2025. Trend: 2023 $2,676 · 2024 $2,781 · 2025 $2,840
Food & beverage: $2,721Education: $119
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 43 | $796 |
| AstraZeneca Pharmaceuticals LP | 16 | $322 |
| Viatris Specialty LLC | 10 | $213 |
| Regeneron Healthcare Solutions, Inc. | 9 | $185 |
| Insmed, Inc. | 15 | $166 |
| Actelion Pharmaceuticals US, Inc. | 8 | $162 |
| Grifols USA, LLC | 6 | $161 |
| Verona Pharma, Inc. | 8 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $131 |
| Amgen Inc. | 6 | $123 |
Products named: NUCALA, DUPIXENT, YUPELRI, Arikayce, Prolastin-C Liquid, TRELEGY ELLIPTA, UPTRAVI, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
